As of 3:59pm ET
| -0.17 / -2.56%|
The 3 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +131.84% increase from the last price of 6.47.
The current consensus among 7 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.